BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22038535)

  • 1. Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.
    Alexander KS; Wu HQ; Schwarcz R; Bruno JP
    Psychopharmacology (Berl); 2012 Apr; 220(3):627-37. PubMed ID: 22038535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine.
    Alexander KS; Pocivavsek A; Wu HQ; Pershing ML; Schwarcz R; Bruno JP
    Neuroscience; 2013 May; 238():19-28. PubMed ID: 23395862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.
    Pershing ML; Bortz DM; Pocivavsek A; Fredericks PJ; Jørgensen CV; Vunck SA; Leuner B; Schwarcz R; Bruno JP
    Neuropharmacology; 2015 Mar; 90():33-41. PubMed ID: 25446576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
    Wu HQ; Pereira EF; Bruno JP; Pellicciari R; Albuquerque EX; Schwarcz R
    J Mol Neurosci; 2010 Jan; 40(1-2):204-10. PubMed ID: 19690987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
    Bortz DM; Wu HQ; Schwarcz R; Bruno JP
    Neuropharmacology; 2017 Jul; 121():69-78. PubMed ID: 28419874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
    Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
    Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.
    Konradsson-Geuken A; Wu HQ; Gash CR; Alexander KS; Campbell A; Sozeri Y; Pellicciari R; Schwarcz R; Bruno JP
    Neuroscience; 2010 Sep; 169(4):1848-59. PubMed ID: 20600676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding.
    Pershing ML; Phenis D; Valentini V; Pocivavsek A; Lindquist DH; Schwarcz R; Bruno JP
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3725-3735. PubMed ID: 27527585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task.
    Phenis D; Vunck SA; Valentini V; Arias H; Schwarcz R; Bruno JP
    Psychopharmacology (Berl); 2020 Jun; 237(6):1723-1735. PubMed ID: 32162104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.
    Wonodi I; Schwarcz R
    Schizophr Bull; 2010 Mar; 36(2):211-8. PubMed ID: 20147364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kynurenine 3-monooxygenase deficiency induces depression-like behavior via enhanced antagonism of α7 nicotinic acetylcholine receptors by kynurenic acid.
    Mori Y; Mouri A; Kunisawa K; Hirakawa M; Kubota H; Kosuge A; Niijima M; Hasegawa M; Kurahashi H; Murakami R; Hoshi M; Nakano T; Fujigaki S; Fujigaki H; Yamamoto Y; Nabeshima T; Saito K
    Behav Brain Res; 2021 May; 405():113191. PubMed ID: 33607168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
    Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
    Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ
    Secci ME; Mascia P; Sagheddu C; Beggiato S; Melis M; Borelli AC; Tomasini MC; Panlilio LV; Schindler CW; Tanda G; Ferré S; Bradberry CW; Ferraro L; Pistis M; Goldberg SR; Schwarcz R; Justinova Z
    Mol Neurobiol; 2019 May; 56(5):3563-3575. PubMed ID: 30151725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential Disruption of Prefrontal GABAergic Function by Nanomolar Concentrations of the α7nACh Negative Modulator Kynurenic Acid.
    Flores-Barrera E; Thomases DR; Cass DK; Bhandari A; Schwarcz R; Bruno JP; Tseng KY
    J Neurosci; 2017 Aug; 37(33):7921-7929. PubMed ID: 28729445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
    Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
    Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats.
    Konradsson-Geuken A; Gash CR; Alexander K; Pomerleau F; Huettl P; Gerhardt GA; Bruno JP
    Synapse; 2009 Dec; 63(12):1069-82. PubMed ID: 19637277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
    Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
    J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors.
    Nikiforuk A; Potasiewicz A; Kos T; Popik P
    Behav Brain Res; 2016 Oct; 313():214-218. PubMed ID: 27435422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood.
    Pocivavsek A; Wu HQ; Elmer GI; Bruno JP; Schwarcz R
    Eur J Neurosci; 2012 May; 35(10):1605-12. PubMed ID: 22515201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.